- CSR Summary Not Yet Available
- NCT04068792
- Primary Citation Trial has yet to be published
- Data Specification Not Available
You are not logged in.
Please login to continue selecting trials.
Trial Information
Generic NameRilematovirProduct NameN/ATherapeutic AreaViral DiseasesEnrollment22% Female31.8%% White4.3%
Product ClassFusion Protein InhibitorSponsor Protocol Number53718678RSV2006Data PartnerJohnson & JohnsonCondition StudiedRespiratory Syncytial VirusesMean/Median Age (Years)3.6
Supporting Documentation
- Collected Datasets Available
- Statistical Analysis Plan Available
- Clinical Study Report Available